Omeros Corporation

Healthcare

NASDAQ:OMER · NASDAQ Global Market

Market Cap $697.70M Beta 2.53 P/E (TTM) 8.4

$10.28 +4.46%

+$0.43 today

52W Low $2.95High $17.65

Vol 2.57M · Avg 1.55M

EPS (TTM) $1.20Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+222.26%

Period High

$17.18

Period Low

$2.97

Latest

$10.28

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

KalVista Pharmaceuticals, Inc.

NASDAQ:KALV

$1.44B

RAPT Therapeutics, Inc.

RAPT

$959.26M

Lexicon Pharmaceuticals, Inc.

NASDAQ:LXRX

$893.63M

4D Molecular Therapeutics, Inc.

NASDAQ:FDMT

$502.37M

Ocugen, Inc.

NASDAQ:OCGN

$426.57M

Bicycle Therapeutics plc

NASDAQ:BCYC

$277.23M

Neumora Therapeutics, Inc. Common Stock

NASDAQ:NMRA

$272.03M

Fulcrum Therapeutics, Inc.

NASDAQ:FULC

$188.97M

ADC Therapeutics S.A.

NYSE:ADCT

$138.00M

Gossamer Bio, Inc.

GOSS

$39.12M

What is the latest OMER filing?

The latest filing shown is 8-K dated Jun 18, 2026.

How many recent filings does OMER have?

Intrinsic Alpha currently shows 20 recent filings for OMER.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.